Status:
COMPLETED
BeSingCardioRehab: CR in Belgium Versus Singapore
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Jessa Hospital
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Background: Cardiac rehabilitation is indicated for ischemic heart disease patients; the program content of which is well described in both European and American guidelines. In contrast, literature on...
Detailed Description
BeSingCardioRehab is an intercontinental, multi-center, retrospective cohort study conducted in two cardiac rehabilitation referral centers (Heart Center Hasselt in Belgium and National Heart Center S...
Eligibility Criteria
Inclusion
- i. patients in the revascularised, stabilized and asymptomatic phase following an acute coronary syndrome (ACS) (unstable angina, non ST-elevation ACS or ST-elevation ACS)
- ii. patients initially presenting with stable angina who are revascularised or asymptomatic under optimal medical treatment (not amenable for revascularization).
Exclusion
- i. end-stage chronic kidney disease (stage V, GFR \< 15 ml/min/1.73 m2 and/or dialysis) ii. severe chronic obstructive pulmonary disease (COPD) (GOLD stage III-IV, Tiffeneau index \< 0.70 and FEV1 \< 49% of normal) iii. terminal cancer with a prognosis of \< 1 year.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
2792 Patients enrolled
Trial Details
Trial ID
NCT03303781
Start Date
April 1 2018
End Date
January 1 2021
Last Update
February 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Hospital
Hasselt, Belgium, 3500
2
National Heart Center Singapore
Singapore, Singapore